In the game of survival, you can't always go it alone. Tiny algae living in the harsh conditions of the world's polar oceans ...

Researchers have identified a promising antiviral compound that blocks hepatitis E replication in early studies. Because it ...

Scientists have discovered a defensive method of cells that resembles Spiderman shooting his web to ensnare enemies. These ...

Researchers identified bemnifosbuvir as a potential treatment for hepatitis E, finding that it inhibited viral replication in ...

Okogen Inc., a biotechnology company developing antiviral therapeutics, today announced the acquisition of the global intellectual property portfolio and development assets for ranpirnase from ...

A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating.

The patented compounds work by inhibiting Vacuolar ATPase (V-ATPase) activity in cells — a host-cell mechanism that viruses ...

For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years of probing work and extensive experimentation, a Yale research team has ...

EMA accepts for review GSK’s MAA for bepirovirsen, an investigational ASO to treat adults with chronic hepatitis B: London, UK Saturday, March 28, 2026, 10:00 Hrs [IST] GSK plc ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Viral Vaccine Cell Culture Media Market size & share revenue was valued at ...